Watch Ticker

Sensei Biotherapeutics, Inc. Common Stock

Go to Sensei Biotherapeutics, Inc. Common Stock Website

$8.24

-0.41 (-4.75%)

Live

Previous Close

$8.65

Day Range

$7.91 - $8.4963

Previous Day Range

$8.045 - $10.635

Market Cap

$13.0 million USD

Day Vol.

7532

Previous Day Vol.

115331

Currency

USD

Primary Exchange

Nasdaq

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics de...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Kuick Research - VISTA Inhibitor Clinical Trials Drug Approval Insight - GlobeNewswire

VISTA inhibitors are an emerging class of immunotherapeutic agents with significant potential in treating cancer and autoimmune diseases. Several companies are actively pursuing VISTA inhibitors, which offer a novel mechanism of action and broad applicability, but also face challenges such as complex development landscape and competition from existing therapies.

Related tickers: CRIS, KA, MRK, SNSE.

Read Full Article

Sensei Biotherapeutics - Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held in New York, NY, on Thursday, June 6, 2024 at 8:30 a.m. ET.

Related tickers: SNSE.

Read Full Article

Trending Tickers

Please sign in to view